Amgen | AMGN - 债务





债务 更改 日
AbbVie USD 72.86B 5.36B 2026-03
Agios Pharmaceuticals USD 35.74M 4.46M 2026-03
ALKERMES USD 1.58B 1.51B 2026-03
Amgen USD 57.32B 2.72B 2026-03
Biogen USD 8.09B 1.53B 2026-06
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 43.37B 867M 2026-03
Exelixis USD 169.54M 3.5M 2026-03
Genmab DKK 5.35B 5.2B 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Glaxosmithkline GBP 19.06B 1.31B 2026-03
Incyte USD 38.27M 1.16M 2026-06
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
J&J USD 54.99B 7.05B 2026-03
Merck USD 49.12B 222M 2026-03
Moderna USD 1.3B 7M 2026-03
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Novartis USD 47B 14.98B 2026-03
Pfizer USD 63.73B 231M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Takeda JPY 4.94T 58.13B 2026-06
Teva Pharmaceutical Industries USD 16.91B 187M 2026-03
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 1.99B 44M 2026-03